TheAdmiral schreef op 8 september 2014 16:49:
Net van de pers:
MDxHealth to Participate in the Rodman & Renshaw 16th Annual Global Investment Conference
IRVINE, California, and HERSTAL, BELGIUM - September 8, 2014 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that the company will participate in the Rodman & Renshaw 16th Annual Global Investment Conference in New York, NY.
Dr. Jan Groen, Chief Executive Officer of MDxHealth, will present a corporate overview at the Rodman & Renshaw 16th Annual Global Investment Conference at the New York Palace Hotel at 4:10 p.m. ET on Tuesday, September 9, 2014